BR9811255A - Processo para preparação de um composto oticamente ativo - Google Patents

Processo para preparação de um composto oticamente ativo

Info

Publication number
BR9811255A
BR9811255A BR9811255-4A BR9811255A BR9811255A BR 9811255 A BR9811255 A BR 9811255A BR 9811255 A BR9811255 A BR 9811255A BR 9811255 A BR9811255 A BR 9811255A
Authority
BR
Brazil
Prior art keywords
preparing
active compound
optically active
products
isoxazoline
Prior art date
Application number
BR9811255-4A
Other languages
English (en)
Inventor
Lin-Hua Zhang
Luigi Anzalone
Jaan A Pesti
Jianguo Yin
Original Assignee
Du Pont Pharm Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Pharm Co filed Critical Du Pont Pharm Co
Publication of BR9811255A publication Critical patent/BR9811255A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/14—Nitrogen or oxygen as hetero atom and at least one other diverse hetero ring atom in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
    • C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
    • C12P41/005—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of carboxylic acid groups in the enantiomers or the inverse reaction

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

<B>"PROCESSO PARA PREPARAçãO DE UM COMPOSTO OTICAMENTE ATIVO"<D> A presente invenção refere-se geralmente a uma transesterificação catalisada por lipase inovadora para a preparação de ácido acético de isoxazolina-5-il com alta pureza ótica a partir de uma mistura estereoisómera de um acetato de isoxazolina-5-il substituído e esterificado. Os produtos são úteis na síntese de compostos para produtos farmacêuticos, especialmente o tratamento de disfunções trombolíticas, e produtos para a agricultura.
BR9811255-4A 1997-03-26 1998-03-26 Processo para preparação de um composto oticamente ativo BR9811255A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4210997P 1997-03-26 1997-03-26
PCT/US1998/005903 WO1998042687A1 (en) 1997-03-26 1998-03-26 Lipase catalyzed dynamic resolution of isoxazoline thioesters to isoxazoline carboxylic acids

Publications (1)

Publication Number Publication Date
BR9811255A true BR9811255A (pt) 2000-07-18

Family

ID=21920103

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9811255-4A BR9811255A (pt) 1997-03-26 1998-03-26 Processo para preparação de um composto oticamente ativo

Country Status (20)

Country Link
US (1) US6022977A (pt)
EP (1) EP0971906A1 (pt)
JP (1) JP2001520672A (pt)
KR (1) KR20010005493A (pt)
CN (1) CN1251095A (pt)
AU (1) AU741040B2 (pt)
BR (1) BR9811255A (pt)
CA (1) CA2283234A1 (pt)
EA (1) EA001970B1 (pt)
EE (1) EE9900434A (pt)
HU (1) HUP0001264A3 (pt)
IL (1) IL132004A0 (pt)
LT (1) LT4674B (pt)
LV (1) LV12431B (pt)
NO (1) NO994480L (pt)
NZ (1) NZ500388A (pt)
PL (1) PL336008A1 (pt)
SI (1) SI20027A (pt)
SK (1) SK131599A3 (pt)
WO (1) WO1998042687A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2803513B1 (fr) * 2000-01-12 2003-12-19 Oreal Utilisation de la dhea et/ou de ses precurseurs ou derives pour ameliorer l'aspect papyrace de la peau
US6624311B2 (en) 2000-10-27 2003-09-23 Bristol-Myers Squibb Pharma Company Enantioselective enzymatic aminolysis of a racemic 2-isoxazolylacetate alkyl ester
GB0306267D0 (en) * 2003-03-19 2003-04-23 Ineos Fluor Ltd Process
CN101643757B (zh) * 2009-09-07 2011-10-19 浙江大学 光学纯n-取代-吗啉-3-酮-2-乙酸的制备方法
ES2846833T3 (es) 2016-07-18 2021-07-29 Janssen Pharmaceutica Nv Ligandos de obtención de imágenes de tau por PET

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4256898A (en) * 1978-05-15 1981-03-17 The Upjohn Company α(substituted) Amino-3-substituted-2-isoxazoline-5-acetic acids (esters)
US4970297A (en) * 1987-03-13 1990-11-13 Syntex (U.S.A.) Inc. Transglutaminase inhibitors
US4933464A (en) * 1988-04-25 1990-06-12 W. R. Grace & Co.-Conn. Process for forming 3-phenylisoxazolines and 3-phenylisoxazoles
US4952700A (en) * 1988-04-25 1990-08-28 W.R. Grace & Co.-Conn. Preparation of isoxazolines and isoxazoles
US5108916A (en) * 1989-06-05 1992-04-28 Rhone-Poulenc Rorer, S.A. Process for stereoselectively hydrolyzing, transesterifying or esterifying with immobilized isozyme of lipase from candida rugosa
CA2023856A1 (en) * 1989-09-26 1991-03-27 Jeffrey M. Howell Enzymatic resolution process
AT398081B (de) * 1991-04-29 1994-09-26 Chemie Linz Gmbh Verfahren zur enzymatischen hydrolyse eines carbonsäurederivates
GB9304351D0 (en) * 1993-03-03 1993-04-21 Chiros Ltd Arylalkanoic acid resolution and microorganisms for use therein
US5489562A (en) * 1993-08-30 1996-02-06 Rohm And Haas Company Herbicide comprising acivicin and α-methyl derivatives thereof
US5849736A (en) * 1993-11-24 1998-12-15 The Dupont Merck Pharmaceutical Company Isoxazoline and isoxazole fibrinogen receptor antagonists
NZ276633A (en) * 1993-11-24 1998-04-27 Du Pont Merck Pharma Isoxazole and isoxazoline derivatives and pharmaceutical compositions thereof
US5446056A (en) * 1993-11-24 1995-08-29 The Du Pont Merck Pharmaceutical Company Isoxazoline compounds useful as fibrinogen receptor antagonists
ATE154932T1 (de) * 1993-11-26 1997-07-15 Pfizer Isoxazolinverbindungen als entzündungshemmende mittel
EP0730587B1 (en) * 1993-11-26 1999-12-08 Pfizer Inc. 3-phenyl-2-isoxazolines as antiinflammatory agents
CA2185019C (en) * 1994-03-09 2000-08-08 Pfizer Limited Isoxazoline compounds as inhibitors of tnf release

Also Published As

Publication number Publication date
KR20010005493A (ko) 2001-01-15
SI20027A (sl) 2000-02-29
CN1251095A (zh) 2000-04-19
EE9900434A (et) 2000-04-17
CA2283234A1 (en) 1998-10-01
LV12431B (en) 2000-07-20
LT4674B (lt) 2000-07-25
HUP0001264A3 (en) 2002-02-28
EA199900874A1 (ru) 2000-04-24
EP0971906A1 (en) 2000-01-19
NO994480D0 (no) 1999-09-16
WO1998042687A1 (en) 1998-10-01
US6022977A (en) 2000-02-08
PL336008A1 (en) 2000-06-05
NO994480L (no) 1999-09-16
AU6941498A (en) 1998-10-20
LT99112A (en) 2000-02-25
AU741040B2 (en) 2001-11-22
NZ500388A (en) 2001-06-29
SK131599A3 (en) 2001-05-10
IL132004A0 (en) 2001-03-19
EA001970B1 (ru) 2001-10-22
LV12431A (lv) 2000-02-20
HUP0001264A2 (hu) 2000-08-28
JP2001520672A (ja) 2001-10-30

Similar Documents

Publication Publication Date Title
PT822935E (pt) Processo para a preparacao de esteres do acido tropinoico enanteomericamente puros
AU5507996A (en) Fatty acid esters as bioactive compounds
ITPD940042A0 (it) Processo per la preparazione di acido ialuronico mediante sintesi enzimatica e relative composizioni farmaceutiche
EP1308553A3 (en) Functional fiber products and process for producing same
CA2393072A1 (en) Mono- and disaccharide derivatives
FI944626A0 (fi) Parannettu menetelmä sakkaridirasvahappopolyesterien valmistamiseksi vaihtoesteröinnillä
BR8901268A (pt) Processo para preparacao de um ester de glicose de superficie ativa de um acido graxo e composicao
ITRM930365A0 (it) Uso di esteri sull&#39;ossidrile della l-carnitina con acidi aromatici perprodurre composizioni farmaceutiche per il trattamento di affezioni cutanee.
ITRM910327A0 (it) Uso di esteri di acil l-carnitine con l&#39;acido gamma-idrossibutirrico per produrre composizioni farmaceutiche per il trattamento di epatopatie.
AU3072889A (en) Process for the preparation of optically active 4-oxo-1- benzopyran-2-carboxylic acid derivatives and intermediates thereof
BR9601310A (pt) Processo para a preparação de um álcool graxo a partir de uma mistura inicial líquida
LV12431A (lv) Lipazes katalizeta izksazolina tioesteru dinamiska parversana izoksazolinkarbonskabes
IT8123391A0 (it) Processo per la preparazione di esteri di acidi arilpropionici otticamente attivi.
TW265365B (pt)
AU9542698A (en) Cosmetic compositions containing azelaic acid
ES2017900A4 (es) Derivados de acido tiazolidina-4-carboxilico, su preparacion y composiciones farmaceuticas conteniendolo
FR2708929B1 (fr) Procédé de préparation d&#39;esters d&#39;acide cyclopropane-1,1-dicarboxylique.
AU5542198A (en) Process for preparing optically active trans-3-substituted glycidic acid ester
AU2395401A (en) Stereospecific hydrolysis of optically active esters
EP0640582A3 (de) Verfahren zur Herstellung von aromatischen Methoxycarbonsäuremethylestern.
AU6349890A (en) Utilization of glutamic acid or gum-arabic as anticomplements
FR2700769B1 (fr) Procede catalytique de transesterification pour la preparation d&#39;esters d&#39;acide (meth)acrylique.
IT8019879A0 (it) Processo per la loro preparazione, esteri di acidi arilpropionici ad e composizioni farmaceutiche attivita&#39; antiinfiammatoria, relative.
IT1193520B (it) Esteri di acidi arilpropilonici ad attivita&#39; antiinfiammatoria,processo per la loro preparazione,e composizioni farmaceutiche relative
IT8921921A0 (it) Processo per la preparazione di esteri degli acidi 2-aril-alcanoici

Legal Events

Date Code Title Description
TE Change of address
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A, 7A, 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1909 DE 07/08/2007.